IRCT20200407046984N1已完成4 期
A comparison of Dabigatran, Enoxaparin and Rivaroxaban for venous thromboembolism prophylaxis in cancer patients
Semnan University of Medical Sciences0 个研究点目标入组 57 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 4 期
- 状态
- 已完成
- 发起方
- 入组人数
- 57
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- no limit 至 no limit（—）
- 性别
- All
入选标准
- •Cancer patients referred to Kosar Hospital in Semnan (all metastatic patients with either progressive symptoms or in the phase of slowing down the disease)
排除标准
- •High blood pressure (180/120 or more)
- •Moderate or severe hepatic insufficiency
- •Glomerular filtration rate (GFR) less than 30ml / min
- •Severe bleeding (requiring hospitalization)
- •Blood and hemorrhagic diseases include: hemophilia, Von Willebrand factor deficiency, problems of factors 2, 5, 7,10 and 12, types of Anemia, blood transfusions, Thrombocytopenia, Bernard-Soulier syndrome, Glanzmann, plaque pool storage deficiency syndrome, Vitamin K deficiency, Dysfibrinogenemia, Immune thrombocytopenia purpura (ITP), Acute lymphoblastic leukemia (ALL), Bleeding diathesis
研究者
相似试验
招募中
4 期
Efficacy and safety of RivaroXaban and DAbigatran versus AcenocouMarol in Cerebral Venous ThrombosisNervous System DiseasesPACTR202202477162480Hasan II University Hospital of Fez60
招募中
3 期
Comparison of rivaroxaban and enoxaparin in the prevention of recurrent venous thromboembolismonhematologic Cancers.Embolism and thrombosis of unspecified arteryI74.9IRCT20201123049469N1Ahvaz University of Medical Sciences50
已完成
2 期
Comparison of Dabigatran and Enoxaparin in prophylaxy of Thromboembolic eventsThromboembolic Disease.198180-189IRCT2013082513828N2?Soicial Security Insurance Office/ Shariati Hospital90
已完成
3 期
Comparison of two kind of drug oral and subcutaneous in prevention of deep vein ?thrombosis in patients admitted to intensive care unitThromboembolism.Embolism and thrombosis of unspecified arteryO88.23IRCT20141209020258N140Arak University of Medical Sciences98
招募中
3 期
Comparison of Rivaroxaban and Enoxaparin to Prevent Deep Vein ThrombosisIRCT20190120042419N1Iran University of Medical Sciences112